RESUMO
Inflammatory bowel disease (IBD) is a serious chronic illness that affects 1 in 200 people in the United States with the majority of new cases of IBD diagnosed in young people under the age of 35. Despite the growing number of people who are diagnosed each year, the consequences of health-related stigma faced by young people grappling with the effects of IBD are understudied. This experimental investigation explored the existence of enacted stigma among college students, a population that faces many social and psychological challenges due to the added emotional stresses brought about by the transition from high school and adolescence to college and adulthood. Results indicate that enacted stigma among college students toward other students with IBD decreases when disclosure of the disease is present. Results also suggest that greater knowledge of the nature and symptoms of IBD positively correlates to decreased stigma.
Assuntos
Revelação , Doenças Inflamatórias Intestinais/psicologia , Estigma Social , Estudantes/psicologia , Adulto , Feminino , Humanos , Masculino , Estudantes/estatística & dados numéricos , Inquéritos e Questionários , Estados Unidos , Universidades , Adulto JovemRESUMO
Patients with inflammatory bowel disease (IBD) do not receive routine preventative care at the same rate as general medical patients. This patient population is at increased risk of vaccine preventable illness such as influenza and pneumococcal pneumonia. This review will discuss health maintenance needs and preventative care issues in patients with IBD.
Assuntos
Neoplasias Colorretais/diagnóstico , Imunossupressores/efeitos adversos , Doenças Inflamatórias Intestinais/terapia , Medicina Preventiva/métodos , Vacinação/métodos , Conservadores da Densidade Óssea/uso terapêutico , Varicela/etiologia , Varicela/imunologia , Varicela/prevenção & controle , Vacina contra Varicela/uso terapêutico , Depressão/diagnóstico , Depressão/terapia , Gerenciamento Clínico , Detecção Precoce de Câncer/métodos , Hepatite Viral Humana/etiologia , Hepatite Viral Humana/imunologia , Hepatite Viral Humana/prevenção & controle , Herpes Zoster/etiologia , Herpes Zoster/imunologia , Herpes Zoster/prevenção & controle , Vacina contra Herpes Zoster/uso terapêutico , Humanos , Hospedeiro Imunocomprometido , Vacinas contra Influenza/uso terapêutico , Influenza Humana/etiologia , Influenza Humana/imunologia , Influenza Humana/prevenção & controle , Sarampo/etiologia , Sarampo/imunologia , Sarampo/prevenção & controle , Vacina contra Sarampo-Caxumba-Rubéola/uso terapêutico , Meningite Meningocócica/etiologia , Meningite Meningocócica/imunologia , Meningite Meningocócica/prevenção & controle , Vacinas Meningocócicas/uso terapêutico , Caxumba/etiologia , Caxumba/imunologia , Caxumba/prevenção & controle , Osteoporose/diagnóstico por imagem , Osteoporose/tratamento farmacológico , Infecções por Papillomavirus/etiologia , Infecções por Papillomavirus/imunologia , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/uso terapêutico , Vacinas Pneumocócicas/uso terapêutico , Pneumonia Pneumocócica/etiologia , Pneumonia Pneumocócica/imunologia , Pneumonia Pneumocócica/prevenção & controle , Rubéola (Sarampo Alemão)/etiologia , Rubéola (Sarampo Alemão)/imunologia , Rubéola (Sarampo Alemão)/prevenção & controle , Abandono do Hábito de Fumar , Vacinas contra Hepatite Viral/uso terapêutico , Vitamina D/uso terapêutico , Deficiência de Vitamina D/diagnósticoRESUMO
Patients with inflammatory bowel disease (IBD) are at an increased risk for vaccine-preventable illnesses, such as pneumococcal pneumonia and influenza. We hypothesized that a patient-directed educational program would increase vaccination rates of patients with IBD. We developed a written educational form that was given to all patients over a 15-month period. The form included information about the importance of vaccination and asked patients about their vaccination status. If patients indicated that they were not vaccinated, they were offered a vaccination at the time of their visit. For influenza, the vaccination rates during 3 seasons were compared. For pneumococcal pneumonia, the vaccination rates during a 6-month period before the introduction of the educational program and the rates during the 15-month period after implementation of the intervention were compared. Our form increased the percentage of patients who reported having an influenza vaccination (23% vs 47%; P<.001) and the percentage of patients who reported having a pneumococcal pneumonia vaccination (21% vs 32%; P<.001). We concluded that a simple written educational form designed to assess vaccination status and enable providers to offer same-day influenza and pneumococcal pneumonia vaccinations resulted in a significant increase in influenza and pneumococcal pneumonia vaccination rates among patients in an IBD specialty clinic.